BioCentury
ARTICLE | Clinical News

OBI-822/821: Phase II/III data

February 29, 2016 8:00 AM UTC

Top-line data from a double-blind, international Phase II/III trial in 349 treatment-experienced patients with histologically or cytologically confirmed metastatic breast cancer showed that OBI-822/82...